Diligence memo · auto-generated · as of July 2, 2026

Navisonics, Inc.

Navisonics, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Navisonics, Inc. operates in Biotechnology, based in Shoreline.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Navisonics, Inc. has raised $835K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $500K on 2014-05-13.

Most recent recorded round closed around 2016-08-23.

Valuation (modeled)modeled

Provath models Navisonics, Inc. at approximately $18M (range $179K–$210M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.87× the median modeled value of Pre-Seed Biotechnology companies in 2016–2018 (152 peers) — value vs value, same stage and era. Within the normal band (87% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 27 months.

Last raise 9.9 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.5× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 16% of Biotechnology peers (4293 compared).

Modeled value ranks above 27% of those peers.

Closest niche peers: New Vital Signs, Inc., Cerebral Magnetics INC, NutriBand Inc., Jivana Biotechnology Inc, AnTolRx, Inc..

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.